Skip to content
10-Q

Quarterly Report

Biora Therapeutics, Inc.

0000950170-24-095491

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 6, 2024 36.47M sh
Shares Diluted Q2 2024 · Jun 30, 2024 74.22M sh
Shares Diluted Q2 2024 · Jun 30, 2024 69.28M sh
Shares Diluted Q2 2024 · Jun 30, 2023 12.14M sh
Shares Diluted Q2 2024 · Jun 30, 2023 11.72M sh
Capex Q2 2024 · Jun 30, 2024 $195K
Capex Q2 2024 · Jun 30, 2023 $36K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$23.45M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$23.72M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $5.1M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$89.32M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$100.19M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$101.42M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$120.88M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$105M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$102.29M
Current Liabilities Q2 2024 · Jun 30, 2024 $45.99M
Current Liabilities Q2 2024 · Dec 31, 2023 $62.97M
Total Liabilities Q2 2024 · Jun 30, 2024 $107.59M
Total Liabilities Q2 2024 · Dec 31, 2023 $132.64M
Current Assets Q2 2024 · Jun 30, 2024 $9.2M
Current Assets Q2 2024 · Dec 31, 2023 $19.07M
Total Assets Q2 2024 · Jun 30, 2024 $18.26M
Total Assets Q2 2024 · Dec 31, 2023 $31.22M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.04
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.06
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.47
Eps Diluted Q2 2024 · Jun 30, 2023 −$3.01
Eps Basic Q2 2024 · Jun 30, 2024 $0.18
Eps Basic Q2 2024 · Jun 30, 2024 $0.07
Eps Basic Q2 2024 · Jun 30, 2023 −$1.47
Eps Basic Q2 2024 · Jun 30, 2023 −$3.01
Sga Expense Q2 2024 · Jun 30, 2024 $8.4M
Sga Expense Q2 2024 · Jun 30, 2024 $17.45M
Sga Expense Q2 2024 · Jun 30, 2023 $8.95M
Sga Expense Q2 2024 · Jun 30, 2023 $17.31M
Rd Expense Q2 2024 · Jun 30, 2024 $7.7M
Rd Expense Q2 2024 · Jun 30, 2024 $14.71M
Rd Expense Q2 2024 · Jun 30, 2023 $5.98M
Rd Expense Q2 2024 · Jun 30, 2023 $13.17M
Net Income Q2 2024 · Jun 30, 2024 $6.47M
Net Income Q2 2024 · Jun 30, 2024 $2.28M
Net Income Q2 2024 · Mar 31, 2024 −$4.19M
Net Income Q2 2024 · Jun 30, 2023 −$17.81M
Net Income Q2 2024 · Jun 30, 2023 −$35.25M
Net Income Q2 2024 · Mar 31, 2023 −$17.44M
Operating Income Q2 2024 · Jun 30, 2024 −$15.79M
Operating Income Q2 2024 · Jun 30, 2024 −$31.3M
Operating Income Q2 2024 · Jun 30, 2023 −$14.93M
Operating Income Q2 2024 · Jun 30, 2023 −$30.48M
Revenue Q2 2024 · Jun 30, 2024 $318K
Revenue Q2 2024 · Jun 30, 2024 $860K
Revenue Q2 2024 · Jun 30, 2023 $2K
Revenue Q2 2024 · Jun 30, 2023 $4K